CXCR4 and lymphoma: As of now, there is only one prospective trial for CXCR4-directed ERT in preparation (COLPRIT trial, Eudra-CT 2015-001817-28), that will primarily investigate the tolerable dose and side effects of such ERT in patients with MM or lymphoma.